Interesting letter from a French group about the problems in meta-analyses about fecal transplant studies, making an humorous and fitting analogy with fish soup and bouillabaisse. #microbiota#fmt https://t.co/NHuFckZ7NM
Results from the #iHMP#MOMS-PI PTB study: #prematurity associated with decreased #Lactobacillus dominance, increased species diversity of the vaginal #microbiome and high expression of vaginal pro inflammatory cytokines. https://t.co/JSnTXY7YZ7
Post-#antibiotic reconstitution of #microbiota is delayed by #probiotics for minimally 6 months compared to „watch and wait“ or auto-#FMT! Eran Elinav, MD, PhD, Weizmann Institute of Science (Israel) @ #GMFH2019
In terms of probiotics, if we compare it to antibiotics, we are in the penicillin era, there is a lot to do! Pinaki Panigrahi MD, PhD, University of Nebraska (U.S.) @ #GMFH2019#microbiota
Christoph Thaiss, PhD, University of Pennsylvania (U.S.) @ #gmfh2019: #Hyperglycemia drives intestinal mucosal barrier disruption and #HbA1c highly correlates with influx of microbial molecules in humans #microbiota
Gary Borisy #eesmicrobiome: landscape is key in ecology, the #microbiome should be studied at the micron scale to identify it’s architecture and answer the question: who is close to whom and what (, and why)? https://t.co/M5Cv32fQob Data on the #tongue#biofilm is coming.
Does #microbiota explain adverse drug reactions? Today's inspiring lecture by Michael Zimmermann #eesmicrobiome: Of course, 66% of drugs are at least metabolized by one bacterium. But how do we get the data for every drug? It’s again a whole new dimension!
New comprehensive overview by Dirk Haller and colleagues on how the gut #microbiome contributes to human health is now available https://t.co/iLFFDlI9Dt